Participant with Sample Clauses

Participant with. ☐ a financial support from Erasmus+ EU funds ☐ a zero-grant ☐ a financial support from Erasmus+ EU funds combined with zero-grant The financial support includes: ☐special needs support [To be completed for invited staff from enterprises and any other participants receiving financial support from Erasmus+ EU funds when the institution/organisation does not already have this information]. Bank account where the financial support should be paid: Bank account holder (if different than participant): Bank name: Clearing/BIC/SWIFT number: Account/IBAN number: Why ‘if applicable » does it mean that the money can be paid in « cash » ? Called hereafter “the participant”, of the other part, Have agreed the Special Conditions and Annexes below which form an integral part of this agreement ("the agreement"): Annex I Staff Mobility Agreement Xxxxx XX General Conditions The terms set out in the Special Conditions shall take precedence over those set out in the annexes. [It is not compulsory to circulate papers with original signatures for Xxxxx X of this document: scanned copies of signatures and electronic signatures may be accepted, depending on the national legislation or institutional regulations.] SPECIAL CONDITIONS
Sample 1Sample 2
AutoNDA by SimpleDocs
Participant with a financial support from EU funds  a zero-grant from EU funds 
Sample 1Sample 2
Participant with. ☐a financial support from Erasmus+ EU funds ☐ a zero-grant [NA to select if applicable] ☐a financial support from Erasmus+ EU funds combined with zero-grant The financial support includes: ☐special needs support Bank account where the financial support should be paid: […] Bank account holder (if different than participant): […] Bank name: […] Clearing/BIC/SWIFT number: […] Account/IBAN number: […] Why ‘if applicable » does it mean that the money can be paid in « cash » ? Called hereafter “the participant”, of the other part, Have agreed the Special Conditions and Annexes below which form an integral part of this agreement ("the agreement"): Annex I Staff Mobility Agreement Xxxxx XX General Conditions Xxxxx XXX Certificate of attendance The terms set out in the Special Conditions shall take precedence over those set out in the annexes. [It is not compulsory to circulate papers with original signatures for Xxxxx X of this document: scanned copies of signatures and electronic signatures may be accepted, depending on the national legislation or institutional regulations.] SPECIAL CONDITIONS
Sample 1
Participant with. ☐a financial support from Erasmus+ EU funds ☐ a zero-grant ☐a financial support from Erasmus+ EU funds combined with zero-grant The financial support includes: ☐special needs support [Key Action 1 – VOCATIONAL EDUCATION AND TRAINING, SCHOOL EDUCATION, ADULT EDUCATION] Dr/Mr/Mrs/Ms [Participant name(s) and forename(s)] Seniority in the position: Nationality: Address: [official address in full] Department/unit: Phone: E-mail: Sex: [M/F] Academic year: 20../20.. The financial support includes: ☐special needs support [To be completed for invited staff from enterprises and any other participants receiving financial support from Erasmus+ EU funds when the institution/organisation does not already have this information]. Bank account where the financial support should be paid: Bank account holder (if different than participant): Bank name: Clearing/BIC/SWIFT number: Account/IBAN number: Why ‘if applicable » does it mean that the money can be paid in « cash » ? Called hereafter “the participant”, of the other part, Have agreed the Special Conditions and Annexes below which form an integral part of this agreement ("the agreement"): Annex I [Key Action 1 – HIGHER EDUCATION] Staff Mobility Agreement [Key Action 1 – SCHOOL EDUCATION] Staff Mobility Agreement [Key Action 1 – VOCATIONAL TRAINING] Work programme [to be signed between sending and receiving organisations] [Key Action 1 – ADULT EDUCATION] ` Staff Mobility Agreement Xxxxx XX General Conditions The terms set out in the Special Conditions shall take precedence over those set out in the annexes. [It is not compulsory to circulate papers with original signatures for Xxxxx X of this document: scanned copies of signatures and electronic signatures may be accepted, depending on the national legislation or institutional regulations.] SPECIAL CONDITIONS
Sample 1
Participant with a financial support from EU funds  a zero-grant from EU funds  a financial support from EU funds combined with zero-grant from EU funds days  The financial support includes: Special needs support  [To be completed for invited staff from enterprises and other participants receiving financial support from EU funds when the institution/organisation does not have already this information]. Bank account where the financial support should be paid: Bank account holder (if different than participant): Bank name: Clearing/BIC/SWIFT number: Account/IBAN number: Called hereafter “the participant” of the other part, have agreed the Special Conditions and Annexes below which form an integral part of this agreement ("the agreement"): Annex I [Key Action 1 – HIGHER EDUCATION] Staff Mobility Agreement [to be signed between sending and receiving organisations] Xxxxx XX General Conditions The terms set out in the Special Conditions shall take precedence over those set out in the annexes. [It is not compulsory to circulate papers with original signatures for Xxxxx X of this document: scanned copies of signatures and electronic signatures may be accepted, depending on the national legislation.]
Sample 1
Participant with. ☐ a financial support from Erasmus+ EU funds ☐ a zero-grant ☐ a financial support from Erasmus+ EU funds combined with zero-grant The financial support includes: ☐special needs support [To be completed for invited staff from enterprises and any other participants receiving financial support from Erasmus+ EU funds when the institution/organisation does not already have this information]. Bank account where the financial support should be paid: Bank account holder (if different than participant): Bank name: Clearing/BIC/SWIFT number: Account/IBAN number: Why ‘if applicable » does it mean that the money can be paid in « cash » ? Called hereafter “the participant”, of the other part, Have agreed the Special Conditions and Annexes below which form an integral part of this agreement ("the agreement"): Annex I Staff Mobility Agreement Xxxxx XX General Conditions [It is not compulsory to circulate papers with original signatures for Xxxxx X of this document: scanned copies of signatures and electronic signatures may be accepted, depending on the national legislation or institutional regulations.]
Sample 1

Related to Participant with

  • Participant See Section 7(a) hereof.

  • Participants The Lender and its participants, if any, are not partners or joint venturers, and the Lender shall not have any liability or responsibility for any obligation, act or omission of any of its participants. All rights and powers specifically conferred upon the Lender may be transferred or delegated to any of the Lender's participants, successors or assigns.

  • Participant Agreement I understand that as a condition for participating in the Program I must comply with the Program’s rules and standards of conduct and follow all reasonable direction of the Program Staff. Failure to comply with the Program’s rules and standards of conduct or failure to comply with the reasonable direction of Program Staff may result in my being dismissed from the Program. Participant Signature: Date: PARENT/LEGAL GUARDIAN AGREEMENT I understand that my child will be subject to the rules and standards of conduct of the Program, Valdosta State University and the University System of Georgia. I further understand that my child’s violation of the rules and standards of conduct or failure to comply with the reasonable direction of Program Staff may result in my child’s dismissal from the Program. I accept responsibility for all costs associated with removing my child from the Program, including but not limited to transportation costs to return the Participant home. I understand that Dismissed Participants are not eligible for a refund of any fees or expenses. Parent/Guardian Signature: Date:

  • Participant Responsibilities You must tell the study investigator if you previously took part in this study, have been in any other study in the past year, or are currently involved in any other study. This includes being in the follow-up visit period of another study • You must agree to the scheduled visits, the study plan, lab tests, study procedures, and diet and activity restrictions (details listed later in this document) • You must not have any significant medical or psychiatric condition, including recent (within the past year) or active suicidal thoughts or behaviors, as determined by the study investigator, which may put your safety at risk or could have an effect on the study results • You may be eligible to participate if you have well controlled hypertension or hyperlipidemia (high cholesterol) by either diet or stable doses of 2 or fewer medications • Your body mass index (BMI) must be between 30 – 40 kg/m2 • You may be asked to provide documentation of your childbearing status • You must be eligible to be prescribed Saxenda, and willing to self-administer according to the approved label • You must not have a history of phototoxicity or photosensitivity • You must not have a current or past diagnosis of type 1 or type 2 diabetes mellitus • You must not have a personal or family history of medullary thyroid cancer (MTC) or multiple endocrine neoplasia, type 2 (MEN2), or suspected MTC as determined by the study investigator • You mut not have active/current gallbladder disease • You must not have acute pancreatitis or a history of pancreatitis in the 12 months before the screening visit • You must not have a major depressive disorder or other sever psychiatric disorders (for example, schizophrenia or bipolar disorder) within 2 years before the screening visit • You must not have any history of a suicide attempt in your lifetime • You must not take any medications (including over-the-counter medications, such as medications for cold or allergies, antacids, herbal supplements, minerals, or vitamins) that are inhibitors or inducers of certain enzymes or proteins within 14 days plus 5 half-lives before the first dose or at any time during the study o The study investigator or study staff will review a list of these medications and substances with you o Before taking any drugs other than the study drugs, you must call the CRU for approval. It must first be approved by the study investigator o You must tell the study staff about any drugs taken during the study o Use of certain medications that are unlikely to interfere with the study results may be allowed but the dose of these background medications should stay the same during the study. • You must not have taken any medications, dietary or herbal supplements that are sensitive CYP3A, BCRP, P-gp/MDRI, OATP1B, or UGT1A1 and UGT1A4 substrates after Day -1 of the study. o The study investigator or study staff will review a list of these medications and substances with you • You must have taken a GLP-1R agonist within 90 days before the first dose of Saxenda • You must not have a known intolerance or hypersensitivity to Saxenda or other GLP-1R agonists • You must not take any investigational product (drug or vaccine) within 30 days before the first dose of this study • You may only participate in one part of this study • You must not have donated blood for at least 60 days before dosing. Plasma (a component of blood) donation may be allowed o You cannot donate any blood or blood products at any time during this study. Donation is not allowed for at least 4 weeks after your last blood draw • You must not have a history of excessive alcohol use or binge drinking and/or other illicit drug use within 6 months before screening o Binge drinking is defined as a pattern of 5 (male) or 4 (female) or more alcoholic drinks in about 2 hours o You should not drink more than 14 alcoholic drinks a week o A drink is defined as 8 oz. (1 cup) of beer, 3 oz. (6 tablespoons) of wine, or 1 oz. (2 tablespoons) of hard liquor • You must not be using/taking any drugs of abuse (such as marijuana, cocaine, opioids, etc.). Urine tests will be done to check for such drugs. o If a test is positive, you will not be allowed in the study o Urine collection may be monitored by a staff member of the same sex o You have the right to refuse to be monitored, but may be disqualified from the study o While in this study, please do not eat anything that contains poppy seeds. They may cause a positive drug test • You must not use tobacco or nicotine-containing products in excess of the equivalent of 5 cigarettes or 2 chews of tobacco per day • You must not use tobacco- or nicotine-containing products for 24 hours before the first dose and while confined to the CRU • Please let us know if you or a relative are a staff member of Pfizer. If so, you may not take part in this study if you or your relative are supervised by the study investigator or are directly involved with the study Activity Restrictions • You will need to stay in the CRU for 24 days starting with check-in o You may need to stay in the CRU for longer if you experience a longer study drug effect. This is for safety reasons o The study investigator or study staff will decide when it is safe for you to leave the CRU • You must not do any strenuous exercise for at least 48 hours before each blood draw for safety labs. Examples of this include heavy lifting, weight training, or aerobics o Walking at a normal pace is allowed • You may be asked to wear a device (similar to a wristwatch) that can be used to alert study staff in case of an emergency • You cannot lie down for 4 hours after dosing on days when blood samples for study drug levels are collected, unless needed for study procedures • You are advised to avoid direct sunlight or any high intensity UV light exposure from your first admission to the CRU through your last follow-up contact with the CRU o You should apply sunscreen with a sun protection factor (SPF) of greater than or equal to 50 and wear eye-protective sunglasses Diet Restrictions • You must not eat or drink anything except water for at least 10 hours before each safety laboratory test • You must not eat or drink anything except water for at least 10 hours before collection of the pre- dose blood sample for study drug and other pre-dose blood samples • You may drink water freely while in the CRU • You must not eat anything for at least 10 hours before eating breakfast • If dosing when an OGTT will be done you must not eat anything for at least 10 hours before dosing and/or OGTT • You must not drink red wine for 7 days before the first dose. Red wine is not allowed through the collection of the last blood sample for study drug • You must not eat or drink anything with alcohol for 24 hours (or as stated above for red wine) before (each) check-in. Alcohol is not allowed through the collection of the last blood sample for study drug in each period o Study staff may check your breath for alcohol. If alcohol is found, you will not be allowed in the study • You must not eat or drink anything with caffeine for 24 hours before dosing. Caffeine is not allowed through the collection of the last blood sample for study drug in each period o Caffeine can be found in different foods and drinks. Some examples include chocolate, coffee, tea, cola, Xx. Xxxxxx®, and Mountain Dew® • You must not eat or drink anything that has grapefruit or grapefruit-related citrus fruits for 7 days before the first dose. These are not allowed through collection of the last blood sample for study drug o Examples of citrus fruits that are not allowed are Seville oranges and pomelos o Fruit juices and smoothies may also contain grapefruit or these citrus fruits • Lunch will be provided about 4–5 hours after dosing • Dinner will be provided about 9-10 hours after dosing • An evening snack may be allowed about 12-13 hours after dosing • If it is necessary to split doses and dose twice a day, the timing of meals or snacks may be changed • Meals (breakfast, lunch, dinner, and evening snacks) will be provided at appropriate times on all other study days o On non-dosing days while in the CRU, meals and evening snacks will be provided at about the same time as when given on dosing days Possible Benefits of the Study This study is for research purposes only. There may be no direct benefit to you from taking part. However, information learned from this study may benefit other people in the future. Alternatives to Participating in this Study This study is for research purposes only. Your alternative is to not take part in the study.

  • DEFERRAL Notwithstanding the foregoing, if the Company shall furnish to Holders requesting registration pursuant to this Section 2.3, a certificate signed by the President or Chief Executive Officer of the Company stating that in the good faith judgment of the Board, it would be materially detrimental to the Company and its shareholders for such registration statement to be filed at such time, then the Company shall have the right to defer such filing for a period of not more than ninety (90) days after receipt of the request of the Initiating Holders; provided, however, that the Company may not utilize this right more than once in any twelve (12) month period; provided further, that the Company shall not register any other of its shares during such twelve (12) month period. A demand right shall not be deemed to have been exercised until such deferred registration shall have been effected.

  • Participant Signature Ratification, Acceptance(A), Approval(AA), Accession(a)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!